PATENT CLAIM ANALYSIS

Application Number: 15991698
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "254000"]

Abstract:
Compositions and methods for treating hyperemia and symptoms in pterygium patients are disclosed. The methods include administration of a multikinase inhibitor, an antimetabolite or a combination thereof to patients in need thereof.

Claim (Index 6):
The method of  claim 3 , wherein the topical ocular formulation further comprises one or more pharmaceutically acceptable excipients.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15991382', '15474620', '15375820', '15700735', '13830819']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8097362909877787
- 35 USC 102 Novelty (BERT): 0.5917871489559596
- Combined Prediction Score: 0.7879413767845969
- Mean Citation Score: 405.954126
- Max Citation Score: 548.7458
- Similarity Product: 414.3733981501104

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test